An interventional study of CODE intervention and Usual care in End of Life, Interdisciplinary Communication and Leadership, sponsored by University Hospital, Ghent. Completed at 1 site in Belgium. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2024-05-09.
Sponsored by University Hospital, Ghent · Not applicable, Interventional, and Supportive care
Over the last few decades the fast technical and medical progress poses a significant challenge to doctors, who are asked to find the right balance between life-prolonging and palliative care. Previous studies suggest that doctors (unconsciously) prefer to remain prognostically uncertain rather than to gather the information that is required to reduce uncertainty and to effectively timely take decisions in the team for the benefit of the patient. To obtain all that information, the doctor in charge of the patient needs to empower clinicians to speak up while guarantying a safe environment. However, creating a safe climate which enhances inter-professional shared decision-making for the benefit of the patient requires specific self-reflective and empowering leadership skills (including the management of group dynamics in the interdisciplinary team).
The aim of this study is to investigate whether coaching doctors in self-reflective and empowering leadership, and in the management of team dynamics with regard to adult hospitalized patients potentially receiving excessive treatment during 4 months 1) improves ethical decision-making (primary objective) and 2) reduces the burden on patients, relatives, clinicians and the society (secondary objective). The improvement in quality of ethical decision-making will be assessed objectively via the incidence of written do-not-intubate and -resuscitate orders (first primary endpoint) in patients potentially receiving excessive treatment and subjectively via the ethical decision-making climate questionnaire that will be filled out by the team (second primary endpoint). In line with the DISPROPRICUS study, patients potentially receiving excessive treatment will be defined as patients who are perceived as receiving excessive treatment by two or more different clinicians in charge of the patient. The probability of being alive, at home with a good quality of life one year after admission was only 7% in patients potentially receiving excessive treatment in this study. Therefore, perceptions of excessive treatment by two or more clinicians are used in this study as a signal to initiate (self-)reflection in team about the quality of care that is provided to the patient and whether the treatment is in balance with the medical condition of the patient and the patient's goal of care
.
572 studies on the registry are indexed under Death; 111 are open to participants now.
This study's enrollment of 125 is close to the median of 133 across 260 interventional studies indexed under Death.
Browse Death studies →University Hospital, Ghent is the lead sponsor of 665 studies on the registry; 156 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria :
Usual care
Other: Usual care
The CODE intervention consists of 4 items, of which individual coaching sessions of 1 hour. In total each doctor taking care of hospitalized patients will be able to receive maximum 16 individual coaching sessions during the 4 months intervention period (one weekly). Every doctor will be invited to participate to at least 8 coaching sessions, to be extended on request, during the intervention period.
Behavioral: CODE intervention
The CODE intervention consists of 1) One interactive session of 2 to 3 hrs focusing on the concepts of medical-ethical decision-making, the psychological challenge of dealing with ethically sensitive medical topics, and empowering leadership. 2) Observation and debrief of the interdisciplinary meeting to enhance self-reflection on empowering leadership and managing group dynamics. 3) Individual coaching on the spot in self-reflective and empowering leadership and in managing groups dynamics with regard to ethical decision-making about patients who are perceived to receive excessive treatment during the intervention period, and in absence of such patients, every item with regard to ethical decision-making that is important for the coachee. 4) During the intervention coaches and doctors in charge will be informed of the presence of a patient potentially receiving excessive treatment in their ward by an electronic alert.
The control group will receive usual care in which the quality of the ethical decision-making is determined by the clinical team according to their usual practice. Except from a treatment-limitation-decisions guideline which focuses on the legal and deontological framework, no other guideline with regard to ethical decision-making has been implemented at the Ghent University Hospital. In one ward (geriatrics), there is a ongoing project in which a clinical nurse specialist stimulates and performes advance care planning conversations with patient and/or relatives at request of the team and who organizes debriefings when needed based on the ethical concerns of the nurses.
Incidence of written do-not-intubate and -resuscitate (DNIR) order between hospital admission and the end of first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Ethical decision-making climate questionnaire (EDMCQ)
Clinician specific endpoint. Factorscores on 7 domains, which is normally distributed, centred at mean of zero, with standard deviation 5.5 (minimum score -25, maximum score 25). Higher scores iindicate higher quality of ethical decision-making
Time frame: at the start and end of the 12 month study period
Incidence of death one year after first hospital admission
Patient-specific endpoint
Time frame: 12 months after first hospital admission
Percentage of patients who achieved the combined one year patient outcome (dead, not at home or utility <0.5 according to the European Quality-of-life 5 dimension instrument (Euro-QOL-5D).
Patient-specific endpoint
Time frame: 12 months after first hospital admission
Number of days admitted in the hospital up the end of the first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Pain according to the Numeral rating scale (NRS) : sum of the average daily score up to the end of first hospital stay
Patient-specific endpoint. Single-item assessment of pain ranging from 0 (no pain) to 10 (worst possible pain).
Time frame: at the end of the 12 months study period
Pain according to the Numeral rating scale (NRS) : number of days with an average score > 3 up to the end of first hospital stay
Patient-specific endpoint. Single-item assessment of pain ranging from 0 (no pain) to 10 (worst possible pain).
Time frame: at the end of the 12 months study period
Potentially inappropriate or burdersome treatments : incidence of achieving the combined patient burdersome treatment endpoint (achieving outcome 9,10,11,12,13,14,15 or 16) up to the end of first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Potentially inappropriate or burdersome treatments : incidence of receiving cardio-pulmonary resuscitation up to the end of first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Potentially inappropriate or burdersome treatments : incidence of admission in the intensive care unit up to the end of first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Potentially inappropriate or burdersome treatments : incidence of invasive mechanical ventilation in the intensive care unit up to the end of first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Potentially inappropriate or burdersome treatments : incidence of non-invasive mechanical ventilation in the intensive care unit up to the end of first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Potentially inappropriate or burdersome treatments : incidence of receiving dialysis up to the end of first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Potentially inappropriate or burdersome treatments : incidence of receiving a surgical procedure up to the end of first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Potentially inappropriate or burdersome treatments : incidence of receiving a chemotherapeutic treatment up to the end of first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Potentially inappropriate or burdersome treatments : incidence of receiving a radiotherapeutic treatment up to the end of first hospital stay
Patient-specific endpoint
Time frame: at the end of the 12 months study period
Satisfaction according to the European Family Satisfaction in the ICU score (Euro FS)
Patient-specific endpoint. The investigators will use the single-item assessment of satisfaction of this score ranging from 0 to 10. Higher values indicate higher satisfaction
Time frame: 3 weeks after hospital discharge
Hospital anxiety and depression scale (HADS)
Patient-specific endpoint. This score is interpreted as follows : 0-7 (normal), 8-10 (mild), 11-21 (moderate to severe)
Time frame: 3 weeks after hospital discharge
European quality of dying and death family questionnaire (Euro-QODD nurse)
Patient-specific endpoint filled out by nurses. The investigators will use the single-item assessment of quality of dying and death of this score ranging from 0 to 10. Higher values indicate higher quality
Time frame: within 1 week after death
European quality of dying and death family questionnaire (Euro-QODD family)
Patient-specific endpoint filled out by the relatives. The investigators will use the single-item assessment of quality of dying and death of this score ranging from 0 to 10. Higher values indicate higher quality
Time frame: 3 weeks after the patient's death
Satisfaction according to the European Family Satisfaction in the ICU score (Euro FS)
Family-specific endpoint. The investigators will use the single-item assessment of satisfaction of this score ranging from 0 to 10. Higher values indicate higher satisfaction
Time frame: 3 weeks after the patient's hospital discharge
Hospital anxiety and depression scale (HADS)
Family-specific endpoint. This score is interpreted as follows : 0-7 (normal), 8-10 (mild), 11-21 (moderate to severe)
Time frame: 3 weeks after the patient's hospital discharge
Impact of events scale-revised (IES-R)
Family-specific endpoint. This score is interpreted as follows: Low risk (0-11), moderate risk (12-32), high risk (33 or higher) for post-traumatic stress disorder.
Time frame: 3 weeks after the patient's death
Percentage of (mild-moderate-severe-extreme) stress related to a perception of excessive treatment
Clinician-specific endpoint
Time frame: at the end of the 12 month study period
Percentage of clinicians with intention of leaving their job
Clinician-specific endpoint
Time frame: at the start and end of the 12 month study period
Percentage of clinicians with sick leave
Team-specific endpoint
Time frame: at the start and end of the 12 month study period
Ethical pratice score
Team-specific endpoint. This scores consist of 12 items. The investigators will use the 10 department specific items (minus the 2 country-specific items). This score ranges from 0 to 10 with higher scores indicating a higher degree of ethical pratice organization
Time frame: at the start and end of the 12 month study period
Health-care utilization : total hospital cost by the hospital billing record up to the end of first hospital stay
Society-specific endpoint
Time frame: at the end of the 12 months study period
Health-care utilization : total number of emergency department visits
Society-specific endpoint
Time frame: 12 months after first hospital discharge
Health-care utilization : total number of hospital admissions
Society-specific endpoint
Time frame: 12 months after first hospital discharge
Health-care utilization : total number of admissions in the intensive care unit
Society-specific endpoint
Time frame: 12 months after first hospital discharge
Health-care utilization : total number of days in the hospital
Society-specific endpoint
Time frame: 12 months after first hospital discharge
Health-care utilization : total number of days in the intensive care unit
Society-specific endpoint
Time frame: 12 months after first hospital discharge
Health-care utilization : total number of dialyses
Society-specific endpoint
Time frame: 12 months after first hospital discharge
Health-care utilization : total number of surgical procedures
Society-specific endpoint
Time frame: 12 months after first hospital discharge
Health-care utilization : total number of chemotherapeutic treatments
Society-specific endpoint
Time frame: 12 months after first hospital discharge
Health-care utilization : total number of radiotherapeutic treatments
Society-specific endpoint
Time frame: 12 months after first hospital discharge
Health-care utilization : total number of blood analyses
Society-specific endpoint
Time frame: 12 months after first hospital discharge
Health-care utilization : total number of radiological investigations
Society-specific endpoint
Time frame: 12 months after first hospital discharge
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Ghent